Sysmex Executive and Leadership Team

Hisashi Ietsugu, the Chief Executive Officer at Sysmex, directs the company's overarching strategy and global operations. Overseeing the development, manufacture, and sale of clinical laboratory instruments, reagents, and software, Ietsugu ensures Sysmex remains at the forefront of in-vitro diagnostics. This leadership role involves guiding the company's expansion across key geographical segments, including Japan, the Americas, Europe, China, and Asia Pacific. By focusing on innovation in hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care testing, Hisashi Ietsugu drives the business towards enhanced accuracy in patient diagnostics and improved healthcare outcomes worldwide. The Chief Executive Officer's vision shapes the company's commitment to advancing medical technology and solidifying its market position.

Christopher Cappella, the Chief Financial Officer at Sysmex, manages the company's financial health and strategic fiscal planning. Cappella oversees all financial operations, including budgeting, forecasting, and resource allocation across Sysmex's global segments: Japan, Americas, Europe, China, and Asia Pacific. This critical role ensures the financial stability required to support the ongoing research and development of advanced clinical laboratory instruments, reagents, and software. By optimizing financial performance, Christopher Cappella enables continued investment in product lines such as hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care testing. The Chief Financial Officer's expertise is vital for driving sustainable growth and maintaining Sysmex's competitive edge in the in-vitro diagnostics market.

Asano Kaoru, the President at Sysmex, drives operational execution and strategic initiatives across the company's global footprint. Kaoru oversees the day-to-day management of Sysmex's diverse product portfolio, including instruments and reagents for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care testing. This leadership position ensures seamless integration of development, manufacturing, and sales activities within the Japan, Americas, Europe, China, and Asia Pacific segments. By focusing on operational efficiency and market responsiveness, Asano Kaoru supports the company's commitment to providing advanced in-vitro diagnostic solutions. The President's role is integral to maintaining Sysmex's reputation for quality and innovation in clinical laboratory testing.

Dorie Blesoff, the Chief People Officer at Sysmex, leads the strategic direction for human capital management and organizational development. Blesoff cultivates a robust company culture that supports Sysmex's mission in developing and distributing cutting-edge clinical laboratory instruments, reagents, and software for in-vitro diagnostics. This executive function ensures that the global workforce across Japan, Americas, Europe, China, and Asia Pacific is aligned with the company's innovative objectives in areas like hemostasis, immunochemistry, and urinalysis. By fostering talent and promoting employee engagement, Dorie Blesoff strengthens the operational capacity needed to advance healthcare solutions. The Chief People Officer's focus on people empowers the teams driving Sysmex's technological advancements and market leadership.